The WAVE trial was designed to evaluate the efficacy ... The proportion of AVG patients who were free from an adverse event was higher than the safety PG. Don't Miss our Black Friday Offers ...
The WAVE trial was designed to evaluate the efficacy ... The proportion of AVG patients who were free from an adverse event was higher than the safety PG (95.4% vs. 89.0%, p=0.0162).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback